Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Vasculopathies and Angiogenesis: Therapeutic Applications and Optimization
Open Access
- 12 July 2023
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 13 (7) , 1109
Abstract
Extracellular vesicles (EVs), as part of the cellular secretome, have emerged as essential cell–cell communication regulators in multiple physiological and pathological processes. Previous studies have widely reported that mesenchymal stromal cell-derived EVs (MSC-EVs) have potential therapeutic applications in ischemic diseases or regenerative medicine by accelerating angiogenesis. MSC-EVs also exert beneficial effects on other vasculopathies, including atherosclerosis, aneurysm, vascular restenosis, vascular calcification, vascular leakage, pulmonary hypertension, and diabetic retinopathy. Consequently, the potential of MSC-EVs in regulating vascular homeostasis is attracting increasing interest. In addition to native or naked MSC-EVs, modified MSC-EVs and appropriate biomaterials for delivering MSC-EVs can be introduced to this area to further promote their therapeutic applications. Herein, we outline the functional roles of MSC-EVs in different vasculopathies and angiogenesis to elucidate how MSC-EVs contribute to maintaining vascular system homeostasis. We also discuss the current strategies to optimize their therapeutic effects, which depend on the superior bioactivity, high yield, efficient delivery, and controlled release of MSC-EVs to the desired regions, as well as the challenges that need to be overcome to allow their broad clinical translation.Keywords
Funding Information
- National Natural Science Foundation of China (82071576, 81871120, 82001466, 2021B1515140058, 2021KCXTD049, 2019KZDXM059, 201901019, 4SG21008G, GDMUB2023006)
- Natural Science Foundation of Guangdong Province (82071576, 81871120, 82001466, 2021B1515140058, 2021KCXTD049, 2019KZDXM059, 201901019, 4SG21008G, GDMUB2023006)
- program for Training High-level Talents of Dongguan (82071576, 81871120, 82001466, 2021B1515140058, 2021KCXTD049, 2019KZDXM059, 201901019, 4SG21008G, GDMUB2023006)
- Discipline construction project of Guangdong Medical University (82071576, 81871120, 82001466, 2021B1515140058, 2021KCXTD049, 2019KZDXM059, 201901019, 4SG21008G, GDMUB2023006)
- Funds for PHD researchers of Guangdong Medical University (82071576, 81871120, 82001466, 2021B1515140058, 2021KCXTD049, 2019KZDXM059, 201901019, 4SG21008G, GDMUB2023006)
This publication has 139 references indexed in Scilit:
- Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion SystemCytotherapy, 2014
- Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging ReporterACS Nano, 2014
- Endothelial Junctional Adhesion Molecule-A Guides Monocytes Into Flow-Dependent Predilection Sites of AtherosclerosisCirculation, 2014
- Mesenchymal stem cell: An efficient mass producer of exosomes for drug deliveryAdvanced Drug Delivery Reviews, 2013
- Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary HypertensionCirculation, 2012
- Is CD34 truly a negative marker for mesenchymal stromal cells?Cytotherapy, 2012
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein deliveryLeukemia, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006